1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Advancement in diagnosis of Castleman's Disease demanded for further treatment options
5.2.2. Increasing prevalence Castleman's Disease among AIDS patients
5.2.3. Government support in research and development of orphan drugs
5.3. Restraints
5.3.1. Premium pricing of drugs
5.3.2. Limited information about current clinical trials of the drugs
5.4. Opportunities
5.4.1. Treatment tailored to each patient's situation
5.4.2. Complementary and alternative methods for treatment
5.5. Challenges
5.5.1. Limited information about causes and treatments of this rare disorder

6. Castleman Disease Treatment Market, by Disease Type
6.1. Introduction
6.2. Multicentric Castleman's Disease
6.3. Unicentric Castleman's Disease

7. Castleman Disease Treatment Market, by Indication
7.1. Introduction
7.2. Angiofollicular Lymph Node Hyperplasia
7.3. Angiomatous Lymphoid
7.4. Castleman Tumor
7.5. Giant Benign Lymphoma
7.6. Giant Lymph Node Hyperplasia
7.7. Hamartoma of the Lyphatics

8. Castleman Disease Treatment Market, by Therapy
8.1. Introduction
8.2. Antiviral Drugs
8.3. Chemotherapy
8.4. Corticosteroids
8.5. Immunotherapy
8.6. Monoclonal Antibodies
8.7. Radiation Therapy

9. Castleman Disease Treatment Market, by Application
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Infectious Diseases

10. Americas Castleman Disease Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Castleman Disease Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Castleman Disease Treatment Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. AbbVie Inc.
14.2. Amgen Inc.
14.3. Bayer AG
14.4. Boehringer Ingelheim GmbH
14.5. Bristol-Myers Squibb
14.6. EUSA Pharma, Inc.
14.7. F. Hoffmann-La Roche Ltd.
14.8. Gilead Sciences, Inc.
14.9. GlaxoSmithKline PLC
14.10. Hospira, Inc.
14.11. Incyte Corporation
14.12. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
14.13. Jazz Pharmaceuticals, Inc
14.14. LGM Pharma
14.15. Merck & Co., Inc.
14.16. NPS Pharmaceuticals, Inc,
14.17. Octapharma AG
14.18. Pfizer, Inc.
14.19. Relypsa, Inc.
14.20. Sanofi S.A.
14.21. Santa Cruz Biotechnology, Inc
14.22. Senhwa Biosciences
14.23. Triveni Interchem Private Limited

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (%)
FIGURE 5. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2026
FIGURE 7. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MULTICENTRIC CASTLEMAN'S DISEASE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MULTICENTRIC CASTLEMAN'S DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY UNICENTRIC CASTLEMAN'S DISEASE, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY UNICENTRIC CASTLEMAN'S DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
FIGURE 12. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2026
FIGURE 14. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ANGIOMATOUS LYMPHOID, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ANGIOMATOUS LYMPHOID, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CASTLEMAN TUMOR, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CASTLEMAN TUMOR, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY GIANT BENIGN LYMPHOMA, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY GIANT BENIGN LYMPHOMA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY GIANT LYMPH NODE HYPERPLASIA, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY GIANT LYMPH NODE HYPERPLASIA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HAMARTOMA OF THE LYPHATICS, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HAMARTOMA OF THE LYPHATICS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY THERAPY, 2020 VS 2026 (%)
FIGURE 27. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY THERAPY, 2020 VS 2026 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY THERAPY, 2026
FIGURE 29. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 39. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY RADIATION THERAPY, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 42. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY APPLICATION, 2026
FIGURE 44. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 46. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 48. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. ASIA-PACIFIC CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. AUSTRALIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. CHINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. INDIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. INDONESIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. JAPAN CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. MALAYSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. PHILIPPINES CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. SINGAPORE CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. SOUTH KOREA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. TAIWAN CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. THAILAND CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. NETHERLANDS CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. QATAR CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. SOUTH AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 79. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CASTLEMAN DISEASE TREATMENT MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MULTICENTRIC CASTLEMAN'S DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY UNICENTRIC CASTLEMAN'S DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ANGIOMATOUS LYMPHOID, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CASTLEMAN TUMOR, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY GIANT BENIGN LYMPHOMA, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY GIANT LYMPH NODE HYPERPLASIA, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HAMARTOMA OF THE LYPHATICS, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY THERAPY, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. ASIA-PACIFIC CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. AUSTRALIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. CHINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. INDIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. INDONESIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. JAPAN CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. MALAYSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. PHILIPPINES CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SINGAPORE CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. SOUTH KOREA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. TAIWAN CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. THAILAND CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. NETHERLANDS CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. QATAR CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. SOUTH AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: SCORES
TABLE 55. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: BUSINESS STRATEGY
TABLE 56. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 57. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: RANKING
TABLE 58. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 59. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: MERGER & ACQUISITION
TABLE 60. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 61. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 62. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 63. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 64. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
Amgen Inc.
Bayer AG
Boehringer Ingelheim GmbH
Bristol-Myers Squibb
EUSA Pharma, Inc.
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline PLC
Hospira, Inc.
Incyte Corporation
Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
Jazz Pharmaceuticals, Inc
LGM Pharma
Merck & Co., Inc.
NPS Pharmaceuticals, Inc,
Octapharma AG
Pfizer, Inc.
Relypsa, Inc.
Sanofi S.A.
Santa Cruz Biotechnology, Inc
Senhwa Biosciences
Triveni Interchem Private Limited